Gerosuppressant Metformin: less is more
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Further expanding the major findings of the landmark study by Harrison and colleagues showing that late-life pharmacological inhibition of the enzyme mammalian Target Of Rapamycin (mTOR) –a conserved integrator of nutrient and growth factor signalingis sufficient to significantly extend lifespan in mice on rapamycin feeding [1], Selman and colleagues have recently revealed that loss of the ribosomal S6 protein kinase S6K1 –a downstream target and effector of mTORcan similarly provide health and longevity effects without detrimental effects when targeted pharmacologically [2]. As previously observed in calorie restriction (CR)related interventions that similarly delayed aging in Caenorhabditis elegans, rodents and rhesus monkeys [3], long-lived S6K1 knockout animals exhibit a reduced body size [2]. Pro-longevity features in animals lacking S6K1, including hyperactivation of the metabolic rheostat adenosine monophosphate (AMP)activated protein kinase (AMPK) and transcriptional alterations of key genes involved in the regulation of glucose and lipid metabolism, paradoxically imitate those observed in reliable models of human progeria in which certain aspects of aging are manifested precociously or in exacerbated form [4]. We have learned that, in their attempt to re-allocate resources from growth to life extension, rapidly aging progeroid mice with nuclear envelope abnormalities –which could also be a central cause of normal agingmetabolically adopt CR-like strategies (i.e. activation of AMPK and inhibition of mTOR/S6K1 leading to extensive activation of autophagic catabolism) aimed to slow-down cellular division-dependent accumulation of Commentaries and Editorials
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“It would be relevant to evaluate whether metformin coexposure may favour the “accelerated senescence” triggered in normal cells by the expression of mutant Ras or Raf (oncogene-induced senescence) and by some other forms of supraphysiological mitogenic signaling [130-132] getting stuck irrespective of senescenceinhibi…”
BackgroundRapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680 · cited 1×
“Women with a mutation have a 65% risk of developing breast cancer before age 70 [78].”
BackgroundFatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 1×
“BRCA1 appears to directly recapitulate the AMPKrelated anti-lipogenic effects of metformin (which rapidly induces inhibitory phosphorylation of AcetylCoA Carboxylase [ACACA] –the first committed molecule in the endogenous pathway of fatty acid biosynthesis-) because specific sequences of BRCA1 have been found to inter…”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688 · cited 1×
“response (DDR), which initiates and maintains the senescence growth arrest, is a crucial anti-cancer barrier in early human tumorigenesis [133, 134], it would be very informative to test if metformin can significantly increase senescence cell abundance in premalignant lesions of the skin, the lung, and the pancreas [1…”
BackgroundMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Confirming and expanding further a landmark study by Evans and colleagues [52], who originally reported that”
ResultGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Colman, R. J., Anderson, R. M., Johnson, S. C., Kastman, E. K., Kosmatka, K. J., Beasley, T. M., Allison, D. B., Cruzen, C., Simmons, H. A., Kemnitz, J. W., et al. (2009) · Science · doi:10.1126/science.1173635 · Cited by 2,277
Four faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 9×
“growth factors such as amphiregulin, cytokines such as IL-6/IL-8, VEGF, matrix metalloproteinases), a probable mechanism through which senescent cells can stimulate tumorigenesis in vivo is the bystander effect of senescent fibroblasts in the adjacent premalignant/malignant cells [96].”
BackgroundInfluentialInsulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · cited 2×
“It should be noted that, when evaluating either how metformin efficacy on tumor growth and metastasis related to dietary energy availability or how metformin can inhibit the generation and/or maintenance of mammary tissue-specific stem cells and their niches, all the above mentioned studies observed or assumed that me…”
BackgroundSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · cited 1×
“It would be relevant to evaluate whether metformin coexposure may favour the “accelerated senescence” triggered in normal cells by the expression of mutant Ras or Raf (oncogene-induced senescence) and by some other forms of supraphysiological mitogenic signaling [130-132] getting stuck irrespective of senescenceinhibi…”
BackgroundCellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708
mTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575
Enhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444
Senescence in tumours: evidence from mice and humans
Collado, M., & Serrano, M. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2772 · Cited by 1,124 · cited 1×
“On the one hand, studies of human tissues and cancer-prone mice argue strongly that cellular senescence suppresses cancer in vivo [112-114].”
BackgroundRibosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120 · cited 17×
“Further expanding the major findings of the landmark study by Harrison and colleagues showing that late-life pharmacological inhibition of the enzyme mammalian Target Of Rapamycin (mTOR) –a conserved integrator of nutrient and growth factor signaling- is sufficient to significantly extend lifespan in mice on rapamycin…”
BackgroundInfluentialHirsch, H. A., Iliopoulos, D., Tsichlis, P. N., & Struhl, K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2994 · Cited by 1,115
Fat tissue, aging, and cellular senescence
Tchkonia, T., Morbeck, D. E., Von Zglinicki, T., Van Deursen, J., Lustgarten, J., Scrable, H., Khosla, S., Jensen, M. D., & Kirkland, J. L. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00608.x · Cited by 1,094 · cited 1×
“If metformin treatment can restore tissue health by actively & selectively removing senescent cells in aging tissues via activation of the immune system, it can be expected that metformin-based interventions could delay age-related onset of chronic diseases more efficiently if started early in life because senescent c…”
BackgroundTumor suppressors and cell metabolism: a recipe for cancer growth
Jones, R. G., & Thompson, C. B. (2009) · Genes & Development · doi:10.1101/gad.1756509 · Cited by 1,085
A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050
Jun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · cited 1×
“A normal senescence response helps to resolve fibrotic scars after acute liver injury whereas a compromised senescence response allows the occurrence of excessive, severe fibrosis [121-123].”
BackgroundThe common biology of cancer and ageing
Finkel, T., Serrano, M., & Blasco, M. A. (2007) · Nature · doi:10.1038/nature05985 · Cited by 988 · cited 1×
“On the one hand, studies of human tissues and cancer-prone mice argue strongly that cellular senescence suppresses cancer in vivo [112-114].”
BackgroundDowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880 · cited 1×
“Finally, because many tumor cells retain the ability to senesce, in culture and in vivo, in response to DNA-damaging chemotherapeutic agents [140-142], it might be tempting to suggest that metformin-enhanced cellular senescence in the context of DDR could explain metformin’s ability to increase the rate of pathologica…”
BackgroundStem cells, ageing and the quest for immortality
Rando, T. A. (2006) · Nature · doi:10.1038/nature04958 · Cited by 695
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies
Lee, J. H., Budanov, A. V., Park, E. J., Birse, R., Kim, T. E., Perkins, G. A., Ocorr, K., Ellisman, M. H., Bodmer, R., Bier, E., et al. (2010) · Science · doi:10.1126/science.1182228 · Cited by 570
Kukidome, D., Nishikawa, T., Sonoda, K., Imoto, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Matsumura, T., & Araki, E. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0943 · Cited by 504
Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess
Wellen, K. E., & Thompson, C. B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.10.004 · Cited by 486 · cited 1×
“Moreover, the well-recognized ability of CR-induced deactivation of the mTOR pathway to slow growth, fitness and the onset of reproduction [10-12] while reducing risk of cancer (i.”
BackgroundAccelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation
Varela, I., Cadiñanos, J., Pendás, A. M., Gutiérrez-Fernández, A., Folgueras, A. R., Sánchez, L. M., Zhou, Z., Rodríguez, F. J., Stewart, C. L., Vega, J. A., et al. (2005) · Nature · doi:10.1038/nature04019 · Cited by 466 · cited 1×
“A mouse model of Hutchinson-Gilford progeria syndrome (HGPS; a childhood premature aging syndrome caused by the accumulation at the nuclear envelop of farnesylated forms of truncated prelamin A –a protein that is also altered during normal aging-) can be extremely informative because it develops phenotypes that overla…”
BackgroundLong-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Bodmer, M., Meier, C., Krähenbühl, S., Jick, S. S., & Meier, C. R. (2010) · Diabetes Care · doi:10.2337/dc09-1791 · Cited by 466
Coppé, J.-P., Patil, C. K., Rodier, F., Krtolica, A., Beauséjour, C. M., Parrinello, S., Hodgson, J. G., Chin, K., Desprez, P.-Y., & Campisi, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009188 · Cited by 455 · cited 1×
“Moreover, senescent cells have been shown to promote malignant progression of pre-malignant epithelial cells –which do not ordinarily form tumors- as well as established cancer cells in in vivo animal models [115-117].”
BackgroundPalomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426 · cited 1×
“Metformin is known to delay premature onset of the menstrual cycle in girls while restoring ovulations in women with premature menopause [44, 45].”
BackgroundJonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency
Baker, D. J., Perez-Terzic, C., Jin, F., Pitel, K. S., Niederländer, N. J., Jeganathan, K., Yamada, S., Reyes, S., Rowe, L., Hiddinga, H. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1744 · Cited by 408 · cited 1×
“Metformin treatment further affects the human transcriptome to modulate numerous genes coding for mitotic checkpoint proteins such as BubR1, which have also been reported to significantly impact on aging [26-28].”
BackgroundThe DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Mallette, F. A., Gaumont-Leclerc, M.-F., & Ferbeyre, G. (2007) · Genes & Development · doi:10.1101/gad.1487307 · Cited by 406
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Kovalenko, I. G., Poroshina, T. E., Semenchenko, A. V., Provinciali, M., et al. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.07.007 · Cited by 402
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence
Lin, H.-K., Chen, Z., Wang, G., Nardella, C., Lee, S.-W., Chan, C.-H., Yang, W.-L., Wang, J., Egia, A., Nakayama, K. I., et al. (2010) · Nature · doi:10.1038/nature08815 · Cited by 400 · cited 2×
“Landmark studies of Lin et al [124] and Campaner et al [125] have recently found that the inhibition of the activity of cyclin dependent kinases (CDKs) plays a significant role in establishing protective cellular senescence; particularly, inhibition of CDK2 activity appears to be critical to lower the bar for triggeri…”
BackgroundMetformin slows down aging and extends life span of female SHR mice
Anisimov, V. N., Berstein, L. M., Egormin, P. A., Piskunova, T. S., Popovich, I. G., Zabezhinski, M. A., Tyndyk, M. L., Yurova, M. V., Kovalenko, I. G., Poroshina, T. E., et al. (2008) · Cell Cycle · doi:10.4161/cc.7.17.6625 · Cited by 348
Anisimov, V. N., Berstein, L. M., Popovich, I. G., Zabezhinski, M. A., Egormin, P. A., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Kovalenko, I. G., et al. (2011) · Aging · doi:10.18632/aging.100273 · Cited by 285 · cited 4×
“Less (accumulation of senescent cells) is More (activity of the immune system) Anisimov and colleagues studied markers of cellular senescence in fibroblasts from skin of SHR mice treated with metformin since the 3rd and the 9th months of life [43].”
BackgroundMethodInfluentialVillaret, A., Galitzky, J., Decaunes, P., Estève, D., Marques, M.-A., Sengenès, C., Chiotasso, P., Tchkonia, T., Lafontan, M., Kirkland, J. L., et al. (2010) · Diabetes · doi:10.2337/db10-0398 · Cited by 282
Cellular senescence controls fibrosis in wound healing
Jun, J.-I., & Lau, L. F. (2010) · Aging · doi:10.18632/aging.100201 · Cited by 255
Vazquez-Martin, A., Oliveras-Ferraros, C., & Menendez, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7499 · Cited by 250 · cited 1×
“Metformin exposure efficiently suppresses S6K1 activity in cultured proliferating epithelial cells [21-23].”
BackgroundSelf-citationMetformin and Other Biguanides in Oncology: Advancing the Research Agenda
Pollak, M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0175 · Cited by 240 · cited 11×
“Giovannucci E, Harlan DM, Archer MC, Bergenstal RM, Gapstur SM, Habel LA, Pollak M, Regensteiner JG, Yee D. Diabetes and cancer: a consensus report.”
BackgroundResultInfluentialCell cycle arrest is not senescence
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100281 · Cited by 217
Cufí, S., Vazquez-Martin, A., Oliveras-Ferraros, C., Martin-Castillo, B., Joven, J., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.22.14048 · Cited by 216 · cited 15×
“Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial‐mesenchymal transition (EMT) status.”
BackgroundInfluentialSelf-citationGauthier, M. L., Berman, H. K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y. Y., Kerlikowske, K., & Tlsty, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.017 · Cited by 214
Metabolic enzymes as oncogenes or tumor suppressors
Thompson, C. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0810213 · Cited by 213
Zakikhani, M., Blouin, M.-J., Piura, E., & Pollak, M. N. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0763-9 · Cited by 213
Suwa, M., Egashira, T., Nakano, H., Sasaki, H., & Kumagai, S. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00255.2006 · Cited by 210
Stressin’ Sestrins take an aging fight
Budanov, A. V., Lee, J. H., & Karin, M. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000097 · Cited by 208 · cited 1×
“Indeed, pharmacological activation of AMPK or inhibition of mTOR prevented age-associated pathologies induced by loss of sestrins [154-157].”
BackgroundMetformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth
Algire, C., Zakikhani, M., Blouin, M.-J., Shuai, J. H., & Pollak, M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0038 · Cited by 185
Revisiting the antagonistic pleiotropy theory of aging: TOR-driven program and quasi-program
Blagosklonny, M. V. (2010) · Cell Cycle · doi:10.4161/cc.9.16.13120 · Cited by 160
A fatty acid synthase blockade induces tumor cell-cycle arrest by down-regulating Skp2
Knowles, L. M., Axelrod, F., Browne, C. D., & Smith, J. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405061200 · Cited by 146 · cited 6×
“As reported by Lin et al [124], Skp2 inactivation on its own failed to induce cellular senescence; however, aberrant protooncogenic signals as well as inactivation of tumor suppressor genes triggered a potent, tumor-suppressive senescence response in mice and cells devoid of Skp2.”
BackgroundInfluentialAdult-onset, short-term dietary restriction reduces cell senescence in mice
Wang, C., Maddick, M., Miwa, S., Jurk, D., Czapiewski, R., Saretzki, G., Langie, S. A. S., Godschalk, R. W. L., Cameron, K., & von Zglinicki, T. (2010) · Aging · doi:10.18632/aging.100196 · Cited by 142 · cited 1×
“Because short-term dietary restriction has recently been shown to decrease abundance of senescent cells as assessed by assaying PCNA (as an indicator of DNA replication), γH2AX (as an indicator of DNA damage) and SA-gal in the liver and intestine of middle-aged mice [100,101], and because γH2AX is a marker of mTOR-de…”
BackgroundEnergy balance and puberty onset: Emerging role of central mTOR signaling
Roa, J., & Tena-Sempere, M. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.05.003 · Cited by 106 · cited 1×
“Moreover, the well-recognized ability of CR-induced deactivation of the mTOR pathway to slow growth, fitness and the onset of reproduction [10-12] while reducing risk of cancer (i.”
BackgroundMetformin induces oxidative stress in white adipocytes and raises uncoupling protein 2 levels
Anedda, A., Rial, E., & González-Barroso, M. M. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0278 · Cited by 98 · cited 3×
“Metformin, as sestrins, can simultaneously function as ROS feedback homeostasis control system and as inhibitor of mTOR.”
BackgroundMetformin activates an ataxia telangiectasia mutated (ATM)/Chk2-regulated DNA damage-like response
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Martin-Castillo, B., & Menendez, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.9.15423 · Cited by 81
Self-citationOliveras-Ferraros, C., Vazquez-Martin, A., & Menendez, J. A. (2009) · Cell Cycle · doi:10.4161/cc.8.10.8406 · Cited by 52 · cited 1×
“Despite overall reduction in global mRNA translation in response to metformininduced dephosphorylation of S6K1 [24], metformin treatment triggers a complex transcriptional program that includes up-regulation of genes coding for several aminoacyl-tRNA synthetases and RNA helicases [25], which might account for yet to b…”
BackgroundSelf-citation
Cited by
Metformin: Multi-faceted protection against cancer
Del Barco, S., Vazquez-Martin, A., Cufí, S., Oliveras-Ferraros, C., Bosch-Barrera, J., Joven, J., Martin-Castillo, B., & Menendez, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.387 · Cited by 302
Self-citationSkinner, H. D., Sandulache, V. C., Ow, T. J., Meyn, R. E., Yordy, J. S., Beadle, B. M., Fitzgerald, A. L., Giri, U., Ang, K. K., & Myers, J. N. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2260 · Cited by 293
Polyphenols, food and pharma. Current knowledge and directions for future research
Tresserra-Rimbau, A., Lamuela-Raventos, R. M., & Moreno, J. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.050 · Cited by 278
Metformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
Vazquez-Martin, A., López-Bonetc, E., Cufí, S., Oliveras-Ferraros, C., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.04.003 · Cited by 66
Metadata
- Authors
- Menendez, J. A., Cufí, S., Oliveras-Ferraros, C., Vellon, L., Joven, J., & Vazquez-Martin, A.
- Venue
- Aging
- Publisher
- Impact Journals, LLC
- Published
- 2011-04-04
- Volume
- 3
- Issue
- 4
- Pages
- 348-362
- ISSN
- 1945-4589 (ISSN-L)
- OpenAlex
- W2288706067
- Cited by
- 58
- References
- 63
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.